Pembrolizumab 200 mg Q3W or 400 mg Q6W: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
2
Conditions studied
0
US states with sites
3
Countries
Phase breakdown
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 1 |
| Metastatic Non-squamous Lung Cancer | 1 |
Recruiting trials involving Pembrolizumab 200 mg Q3W or 400 mg Q6W
Common questions
How many recruiting trials involve Pembrolizumab 200 mg Q3W or 400 mg Q6W?
1 recruiting trial across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.